Search Results - "Burra, Patrizia"

Sars‐Cov‐2 vaccination in liver transplant recipients: The 'holy grail' in a hostile environment.

Authors: Burra, Patrizia Russo, Francesco Paolo

Source: Liver International. Jun2022, Vol. 42 Issue 6, p1225-1228. 4p. 1 Chart.

Safety and efficacy of everolimus initiation from the first month after liver transplantation: A systematic review and meta‐analysis.

Authors: Cholongitas, Evangelos Burra, Patrizia Vourli, Georgia et al.

Source: Clinical Transplantation. May2023, Vol. 37 Issue 5, p1-8. 8p.

Switch from intravenous or intramuscular to subcutaneous hepatitis B immunoglobulin: effect on quality of life after liver transplantation.

Authors: Volpes, Riccardo Burra, Patrizia Germani, Giacomo et al.

Source: Health & Quality of Life Outcomes. 4/10/2020, Vol. 18 Issue 1, p1-7. 7p.

Chronic Hepatitis B in the Transplant Setting: A 30-Year Experience in a Single Tertiary Italian Center.

Authors: Russo, Francesco Paolo Battistella, Sara Zanetto, Alberto et al.

Source: Viruses (1999-4915). Apr2025, Vol. 17 Issue 4, p454. 14p.

Validation of the INCREMENT‐SOT‐CPE score in a large cohort of liver transplant recipients with carbapenem‐resistant Enterobacterales infection.

Authors: Rinaldi, Matteo Bonazzetti, Cecilia Gallo, Mena et al.

Source: Transplant Infectious Disease. Apr2023, Vol. 25 Issue 2, p1-9. 9p.

Somatic Copy Number Alterations in Circulating Cell-Free DNA as a Prognostic Biomarker for Hepatocellular Carcinoma: Insights from a Proof-of-Concept Study.

Authors: Pinto, Elisa Lazzarini, Elisabetta Pelizzaro, Filippo et al.

Source: Cancers. Apr2025, Vol. 17 Issue 7, p1115. 15p.

Prothrombin time predicts steroid response in severe alcohol‐related hepatitis.

Authors: Tarli, Claudia Mannucci, Sergio Vecchione, Michele et al.

Source: Liver International. Mar2024, Vol. 44 Issue 3, p823-830. 8p.

State of the art treatment of hepatitis B virus hepatocellular carcinoma and the role of hepatitis B surface antigen post‐liver transplantation and resection.

Authors: Schemmer, Peter Burra, Patrizia Hu, Rey‐Heng et al.

Source: Liver International. Feb2022, Vol. 42 Issue 2, p288-298. 11p. 3 Diagrams, 1 Chart.

Exploring the impact of stigmatization on mental health in persons with liver disease: a scoping review.

Authors: Romão, Mateus Eduardo Velayatinari, Fateme Monaci, Michela et al.

Source: Psychology, Health & Medicine. Feb2026, p1-28. 28p. 2 Illustrations.

Drug-Induced Liver Injury: Role of Circulating Liver-Specific microRNAs and Keratin-18.

Authors: Cardin, Romilda Bizzaro, Debora Russo, Francesco Paolo et al.

Source: Gastroenterology Insights. Dec2024, Vol. 15 Issue 4, p1093-1105. 13p.

Increased platelet ratio in patients with decompensated cirrhosis indicates a higher risk of portal vein thrombosis.

Authors: Zanetto, Alberto Campello, Elena Burra, Patrizia et al.

Source: Liver International. Jan2023, Vol. 43 Issue 1, p155-159. 5p. 2 Charts.

Normal cortical regional cerebral blood flow justifies the normal neuropsychological performance in patients with cholestatic liver disease.

Authors: SENZOLO, MARCO PIZZOLATO, GILBERTO DAM, MAURO et al.

Source: Psychiatry & Clinical Neurosciences. Apr2007, Vol. 61 Issue 2, p209-210. 2p. 1 Graph.

Subjects: Letters to the editor, Neuropsychology

Clinical impact of sexual dimorphism in non‐alcoholic fatty liver disease (NAFLD) and non‐alcoholic steatohepatitis (NASH).

Authors: Burra, Patrizia Bizzaro, Debora Gonta, Anna et al.

Source: Liver International. Aug2021, Vol. 41 Issue 8, p1713-1733. 21p. 1 Diagram, 2 Charts.

Reply to "Peripheral versus central venous blood sampling does not influence the assessment of platelet activation in cirrhosis".

Authors: Shalaby, Sarah Zanetto, Alberto Campello, Elena et al.

Source: Platelets. 2022, Vol. 33 Issue 7, p1104-1106. 3p.

Primary Sclerosing Cholangitis-Associated Cholangiocarcinoma: From Pathogenesis to Diagnostic and Surveillance Strategies.

Authors: Catanzaro, Elisa Gringeri, Enrico Burra, Patrizia et al.

Source: Cancers. Oct2023, Vol. 15 Issue 20, p4947. 23p.

Long-Term Impact of Direct-Acting Antivirals on Liver Fibrosis and Survival in HCV-Infected Liver Transplant Recipients.

Authors: Gambato, Martina Manuli, Chiara Lynch, Erica N. et al.

Source: Viruses (1999-4915). Aug2023, Vol. 15 Issue 8, p1702. 13p.

Liver Transplantation for Alcoholic Liver Disease and Hepatocellular Carcinoma.

Authors: Burra, Patrizia Zanetto, Alberto Germani, Giacomo

Source: Cancers. Feb2018, Vol. 10 Issue 2, p46. 16p.

Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study.

Authors: Rinaldi, Matteo Bartoletti, Michele Ferrarese, Alberto et al.

Source: Transplant Infectious Disease. Aug2021, Vol. 23 Issue 4, p1-9. 9p.

The Role of Antiviral Prophylaxis in Preventing HBV and HDV Recurrence in the Setting of Liver Transplantation.

Authors: Battistella, Sara Zanetto, Alberto Gambato, Martina et al.

Source: Viruses (1999-4915). May2023, Vol. 15 Issue 5, p1037. 11p.

The role of preoperative optimization of the nutritional status on the improvement of short‐term outcomes after liver transplantation? A review of the literature and expert panel recommendations.

Authors: Victor, David W. Zanetto, Alberto Montano‐Loza, Aldo J. et al.

Source: Clinical Transplantation. Oct2022, Vol. 36 Issue 10, p1-11. 11p.